Form 8-K - Current report:
SEC Accession No. 0001193125-22-231825
Filing Date
2022-08-29
Accepted
2022-08-29 07:01:32
Documents
12
Period of Report
2022-08-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d379797d8k.htm   iXBRL 8-K 21390
  Complete submission text file 0001193125-22-231825.txt   138236

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA iart-20220825.xsd EX-101.SCH 2858
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE iart-20220825_lab.xml EX-101.LAB 17237
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iart-20220825_pre.xml EX-101.PRE 10814
6 EXTRACTED XBRL INSTANCE DOCUMENT d379797d8k_htm.xml XML 3282
Mailing Address 1100 CAMPUS ROAD PRINCETON NJ 08540
Business Address 1100 CAMPUS ROAD PRINCETON NJ 08540 6092750500
INTEGRA LIFESCIENCES HOLDINGS CORP (Filer) CIK: 0000917520 (see all company filings)

EIN.: 510317849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26224 | Film No.: 221207167
SIC: 3841 Surgical & Medical Instruments & Apparatus